0
Clinicopathologic Report |

Acute Unilateral Corneal Immunoprotein Deposition in IgM Monoclonal Gammopathy FREE

Lee P. Schelonka, MD, PhD; Gregory S. H. Ogawa, MD; Terrence P. O'Brien, MD; W. Richard Green, MD
[+] Author Affiliations

W. Richard Green, MD
IndividualAuthor
From the Department of Internal Medicine (Dr Schelonka) and Department of Surgery, Division of Ophthalmology (Dr Ogawa), University of New Mexico School of Medicine, Albuquerque; and the Department of Ophthalmology (Dr O'Brien) and Eye Pathology Laboratory (Dr Green), Wilmer Eye Institute, The Johns Hopkins University, Baltimore, Md.

Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
Arch Ophthalmol. 2000;118(1):125-126. doi:10.1001/archopht.118.1.125
Text Size: A A A
Published online

A healthy 43-year-old officer of a merchant ship at sea developed pain, redness, and photophobia in his right eye. During the next 2 weeks, he noted the presence of a band of opacity spreading from his temporal limbus toward his central cornea. His episcleral vessels were engorged in a distribution contiguous with the peripheral, sectorial, flecklike corneal opacities. The opacity had progressed during topical and systemic antibiotic therapy, but halted with use of topical corticosteroids. Systemic evaluation showed mild IgM monoclonal gammopathy. Transmission electron microscopy of a corneal biopsy specimen revealed electron-dense fibrils identified as immunoprotein. To our knowledge, this is the first report of a case of acute unilateral deposition of corneal immunoprotein in a patient with monoclonal gammopathy. Clinicians should begin with a broad differential diagnosis when evaluating patients with corneal opacity.

Figures in this Article

Immunoprotein deposition is a rare cause of corneal opacity. In general, the immunoprotein deposits occur bilaterally, with gradual onset. We report a case of immunoprotein deposition in the right cornea of a 43-year-old British sailor, 2 weeks following the onset of redness and pain in that eye. We believe that this is the first reported case of acute-onset unilateral corneal immunoprotein deposition in a patient with a monoclonal gammopathy.

The 43-year-old first officer on a British merchant ship sailing in the North Atlantic noted pain and redness of his right eye in July 1993. He could not recall any recent eye injury. As the ship's medical officer, he treated himself with topical chloramphenicol and tetracycline and oral erythromycin. His pain resolved, but the redness remained and he developed photophobia and blurry vision; after 2 weeks, part of his right iris appeared lighter in color.

On examination 3 weeks after the onset of symptoms, the patient's visual acuity without correction was 20/25 OD and 20/20 OS. Slitlamp examination showed a 5.3-mm-wide band of multiple, punctate, flecklike corneal opacities, mostly at the level of the posterior stroma, extending from the inferotemporal limbus toward the center of the right cornea. Also, a 2.2-mm-wide band of similar opacities was noted at the nasal limbus. The remainder of the ophthalmic and general medical examination results were within normal limits. Serologic testing and cultures of blood and urine and skin biopsy specimens were negative for bacteria, fungi, and parasites. The patient was given topical prednisolone every 2 hours and topical polymyxin 3 times a day. He experienced no improvement after 5 days and was referred for further evaluation.

At the Wilmer Eye Institute, Baltimore, Md, the patient's visual acuity and ophthalmic examination results were essentially unchanged. An asymmetric distribution of episcleral hyperemia coincided with the inferotemporal and nasal bands of opacity (Figure 1). The left eye was unremarkable. Serum immunoelectrophoresis demonstrated a mild IgM monoclonal gammopathy. Four months later, while the the patient was receiving topical prednisolone, the wide inferotemporal corneal band had not progressed and the periphery of the band was clearing. The IgM level was 2.2 g/L (normal range, 0.6-2.1 g/L).

Place holder to copy figure label and caption
Figure 1.

Slitlamp photographs of a patient with corneal immunoprotein deposition. Left, Before corneal biopsy. The inferotemporal band of deposition is clearly visible. There is a subtle asymmetry in the episcleral and conjunctival hyperemia, which is greater in the area contiguous with the inferotemporal band. Right, After corneal biopsy. The slitlamp beam indicates the posterior stomal location of the deposition. The nasal band of deposition is also visible.

Grahic Jump Location

A right inferotemporal corneal biopsy was performed. One portion of the tissue was fixed in formalin for light microscopy. A second portion was fixed in a buffered mixture of 1% glutaraldehyde and 4% formaldehyde for transmission electron microscopy.

The part of the biopsy specimen processed for light microscopy showed no corneal deposits. Transmission electron microscopy revealed electron-dense fibrils with a faint periodicity of 16.6 nm (Figure 2). These fibrils had the characteristic appearance of immunoprotein.

Place holder to copy figure label and caption
Figure 2.

Transmission electron micrograph of the corneal biopsy specimen. Electron-dense fibrils with a faint periodicity at 16.6 nm are present.

Grahic Jump Location

Diffuse or focal corneal immunoprotein deposits are a relatively uncommon manifestation of several systemic illnesses, including multiple myeloma,1 monoclonal gammopathy of unknown significance,2 Waldenstrom macroglobulinemia,3 certain lymphoproliferative disorders,4 and leukemia.5 The deposits can be initial or early manifestations of these systemic illnesses.1 ,3 5 Deposits generally develop gradually1 5 and involve both eyes.1 4 Although some patients experience no reduction in visual acuity, many require treatment of the underlying disease with cytotoxic chemotherapy or corticosteroids to restore visual function, and penetrating keratoplasty may be required in severe cases.3 Based on initial evaluation, the patient in this case seemed to have monoclonal gammopathy of unknown significance.

Close examination of the distribution of engorged ocular surface vessels depicted in Figure 1, left, suggests a connection between the inflammatory process and the immunoprotein deposits. The inferotemporal and inferonasal quadrants show significant hyperemia, with dilated conjunctival and episcleral vessels, suggesting bisectoral episcleritis. The bands of immunoprotein are widest in the locations where there is significant hyperemia. In this patient, dilated, permeable vessels may have allowed exudation of large IgM molecules. Although some researchers argue that the tear film is a transport medium for immunoproteins into the cornea,6 this case is most consistent with recent reports indicating the paralimbal vascular arcades as the principal route of influx.2

The response of this patient to topical corticosteroid therapy also suggests an inflammatory leakage mechanism. Topical prednisolone apparently halted the central progression of the corneal deposit, and spared the patient significant loss of visual acuity. The rapid progression of this patient's corneal deposition, although not documented by an ophthalmologist, is likely to be correct since the patient was the ship's medical officer and provided written records of his course prior to evaluation. This case widens the spectrum of findings of corneal immunoprotein deposition, and reminds us to begin with a broad differential diagnosis when evaluating patients with corneal opacity.

Accepted for publication September 10, 1999.

This study was supported in part by the University of New Mexico Foundation's Cornea and Anterior Segment Research Fund, Albuquerque.

Reprints: Gregory S. H. Ogawa, MD, Department of Surgery, Division of Ophthalmology, University of New Mexico School of Medicine, 2211 Lomas Blvd NE, Albuquerque, NM 87131-5341 (e-mail: gogawa@salud.unm.edu).

Perry  HD, Donnenfeld  ED, Font  RL. Intraepithelial corneal immunoglobulin crystals in IgG-kappa multiple myeloma. Cornea. 1993;12448- 450
Henderson  DW, Stirling  JW, Lipsett  J, Rozenbilds  MA, Roberts-Thomson  PJ, Coster  DJ. Paraproteinemic crystalloidal keratopathy. Ultrastruct Pathol. 1993;17643- 668
Gloor  B. Diffuse Hornhautdegeneration bei einem Fall von Makroglobulinamie Waldenstroem. Ophthalmologica. 1968;155449- 463
Miller  KH, Green  WR, Stark  WJ, Wells  HA, Mendelsohn  G, Kanhofer  H. Immunoprotein deposition in the cornea. Ophthalmology. 1980;87944- 950
Eiferman  RA, Levartovsky  S, Schulz  JC. Leukemic corneal infiltrates. Am J Ophthalmol. 1988;105319- 320
McDonnell  PJ, Schanzlin  DJ, Rao  NA. Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol. 1988;1061423- 1425

First Page Preview

First page PDF preview

Figures

Place holder to copy figure label and caption
Figure 1.

Slitlamp photographs of a patient with corneal immunoprotein deposition. Left, Before corneal biopsy. The inferotemporal band of deposition is clearly visible. There is a subtle asymmetry in the episcleral and conjunctival hyperemia, which is greater in the area contiguous with the inferotemporal band. Right, After corneal biopsy. The slitlamp beam indicates the posterior stomal location of the deposition. The nasal band of deposition is also visible.

Grahic Jump Location
Place holder to copy figure label and caption
Figure 2.

Transmission electron micrograph of the corneal biopsy specimen. Electron-dense fibrils with a faint periodicity at 16.6 nm are present.

Grahic Jump Location

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Perry  HD, Donnenfeld  ED, Font  RL. Intraepithelial corneal immunoglobulin crystals in IgG-kappa multiple myeloma. Cornea. 1993;12448- 450
Henderson  DW, Stirling  JW, Lipsett  J, Rozenbilds  MA, Roberts-Thomson  PJ, Coster  DJ. Paraproteinemic crystalloidal keratopathy. Ultrastruct Pathol. 1993;17643- 668
Gloor  B. Diffuse Hornhautdegeneration bei einem Fall von Makroglobulinamie Waldenstroem. Ophthalmologica. 1968;155449- 463
Miller  KH, Green  WR, Stark  WJ, Wells  HA, Mendelsohn  G, Kanhofer  H. Immunoprotein deposition in the cornea. Ophthalmology. 1980;87944- 950
Eiferman  RA, Levartovsky  S, Schulz  JC. Leukemic corneal infiltrates. Am J Ophthalmol. 1988;105319- 320
McDonnell  PJ, Schanzlin  DJ, Rao  NA. Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol. 1988;1061423- 1425

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles